Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

BACKGROUND. Type 2 diabetes mellitus (T2DM) is associated with increased risk of colon cancer (CC), whereas metformin use seems to be protective. However, the impact of metformin use on the risk of death or disease recurrence after radical surgery for CC remains uncertain. MATERIALS AND METHODS. Thi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Vernieri, Claudio, Galli, Fabio, Ferrari, Laura, Marchetti, Paolo, Lonardi, Sara, Maiello, Evaristo, Iaffaioli, Rosario V., Zampino, Maria G., Zaniboni, Alberto, De Placido, Sabino, Banzi, Maria, Damiani, Azzurra, Ferrari, Daris, Rosati, Gerardo, Labianca, Roberto F., Bidoli, Paolo, Frassineti, Giovanni L., Nicolini, Mario, Pavesi, Lorenzo, Tronconi, Maria C., Buonadonna, Angela, Ferrario, Sabrina, Re, Giovanni Lo, Adamo, Vincenzo, Tamburini, Emiliano, Clerico, Mario, Giordani, Paolo, Leonardi, Francesco, Barni, Sandro, Ciarlo, Andrea, Cavanna, Luigi, Gori, Stefania, Cinieri, Saverio, Faedi, Marina, Aglietta, Massimo, Antista, Maria, Dotti, Katia F., Galli, Francesca, Di Bartolomeo, Maria
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Gastrointestinal Cancer
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6519752/
https://ncbi.nlm.nih.gov/pubmed/30606884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0442
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares